Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Anti-free-radical activity" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to the general property or function by which molecules—primarily antioxidants—neutralize free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby preventing cellular and molecular damage caused by oxidative stress. This term encompasses a wide range of endogenous enzymes like superoxide dismutase, catalase, and glutathione peroxidase as well as nonenzymatic antioxidants including vitamins C and E. These agents act through various mechanisms such as hydrogen atom transfer or electron donation to stabilize free radicals[1][2][3]. The concept is relevant in the context of many diseases where oxidative stress plays a role; however, "anti-free-radical activity" itself does not refer to a single protein, gene product, or druggable entity but rather describes an overall biochemical capability found in diverse molecules[1][2][4]. Therefore, it should not be considered a canonical therapeutic target. If you are seeking structured information about specific antioxidant enzymes or compounds with anti-free-radical properties—such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase—or drugs that modulate these pathways, those should be listed individually under their respective names rather than under the generic functional term "anti-free-radical activity"[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-free-radical activity.